Accessing Peripheral Occluded LesiOns II (APOLO-II) — APOLO-II

Femoropopliteal Occlusive Disease Clinical Trial

Official title:
Accessing Peripheral Occluded LesiOns II (APOLO-II)

Status Withdrawn

Clinical Trial Summary

The current study is a prospective, single-arm, non-randomized, multi-center study to evaluate the outcome of the ENABLER-P Catheter System for crossing chronic total occlusions during endovascular intervention for femoral-popliteal occlusive disease.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Femoropopliteal Occlusive Disease

Clinical Trial Details

NCT number	NCT01884701
Study type	Interventional
Source	EndoCross Ltd.
Contact
Status	Withdrawn
Phase	Phase 3
Start date	June 2013

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT05082532` - Efficacy and Safety of Interwoven Self-Expandable Nitinol Stent for Femropopliteal Arterial Occlusive Diseases	N/A
Completed	`NCT03414515` - Endovascular Treatment of Peripheral Artery Disease (PAD)
Terminated	`NCT03346577` - Endovascular Treatment of Peripheral Artery Disease
Recruiting	`NCT04698304` - The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions
Completed	`NCT02939924` - Treatment of Patients With Lesions in the Superficial Femoral and/ or Popliteal Arteries Using Kanshas Paclitaxel-coated Balloon Catheter.	N/A
Recruiting	`NCT01514916` - New Anastomotic Device for End to End Vascular Anastomosis in the Treatment of Peripheral Vascular Disease	N/A